Nalaganje...
Immuno-targeting of pancreatic cancer stem cells: A new therapeutic strategy against a devastating disease?
Pancreatic cancer is a highly aggressive and deadly disease harboring a distinct population of cancer stem cells (CSC) that is not affected by conventional therapies. A new therapeutic approach using the EpCAM/CD3-bispecific antibody MT110 is capable of activating and redirecting cytotoxic T cells t...
Shranjeno v:
Main Authors: | , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Landes Bioscience
2012
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3382890/ https://ncbi.nlm.nih.gov/pubmed/22754787 |
Oznake: |
Označite
Brez oznak, prvi označite!
|